IPAQ Greene (1998) 134 120 SPSS 10 for windows t a.05. 33
34 (Journal of American Medicine Association, JAMA) 2002 2004 (hormone replacement therapy) 1998 JAMA 2003 1998 2003 2004 2002 2000
Robyn (2000) (Aiello, 2004 Lindh-Astrand, 2004 Collins, 1994 Daley, 2006, 2007, 2008 2003 2005 2010 35
45-60 2009 3 1 4 30 7 134 120 (Body Mass Index, BMI) (IPAQ) 7 (Content validity Index,CVI) 98 0.72 0.93 Spearman s rho 0.67 2004 2005 IPAQ 7 (metabolic equivalent,met) (MET) 8.0 4.0 36
3.3 (METs-min/wk) 3 1500METs 7 3000METs 3 20 5 30 5 600METs Greene (1998) Cronbach a.93 SPSS10 134 120 71 49 50 48 22 37
4 19 15 12 20 38 28 19 9 12 24 F=0.77, P>.05 Daley (2008, 2007) F=2.32, p<.05 Stadberg (2000) (Body Mass Index, BMI) BMI 27 27 t=2.98, p<.05 whiteman (2003) t=0.54, p>.05 t=1.86, p>.05 t=-0.543, p>.05 t=0.3, p>.05 12 t=-1.99, p<.05 2001 Dr. Blair 38
39 2002 2002 2004
50 41.7 48 40 22 18.3 120 100 73 60.8 12 10 20 16.6 3 2.5 1 0.8 0 0 0 0 1 0.8 10 8.3 x2 x1 x1 x1 x1 x1 B x3 38 31.7 82 68.3 120 100 9 7,5 1915.8 92 76.7 120 100 12 10 108 90 120 100 24 20 96 80 120 100 40
1 1.31 ±2.88 2 1.11 ±1.12 3 0.94 ±0.97 4 0.87 ±0.99 5 0.76 ±0.83 6 0.76 ±0.93 7 0.69 ±0.89 8 0.65 ±0.87 9 0.60 ±0.93 10 0.58 ±0.81 11 0.56 ±0.81 12 0.56 ±.83 13 0.56 ±0.89 14 0.55 ±0.78 15 0.50 ±0.74 16 0.48 ±0.74 17 0.47 ±0.72 18 0.46 ±0.74 19 0.43 ±0.69 20 0.42 ±0.75 41
F.200 2 9.98E-02.77.464 15.09 117.129 15.29 119 F 1.67 3 0.28 2.32.038 * 13.62 116 0.12 15.29 119 *p<.05 Tukey BMI kg/m 2 BMI t t 27 19 0.77 ±0.46 2.98 118.003 * 27 101 0.51 ±0.32 *p<.05 t t 12 0.60 ±0.25 0.54 118.590 108 0.55 ±0.37 t t 20 0.68 ±0.51 1.86 118.065 100 0.52 ±0.31 42
t t 38 0.58 ±0.34-0.543 118.588 82 0.54 ±0.37 t t 28 0.57 ±.31 0.30 118.763 92 0.55 ±.37 t t 12 0.74 ±.29-1.99 118.049 * 108 0.53 ±.36 *p<.05 1995 150 43
2003 35 1-14 2003 17 1 16-23 2005 2000 8 1 71-84 2003 22 4 245-150 1998 9 145-185 1998 6 6 448-460 2004 51 1 9-13 2004-219 36-39 2004 2006-2002 49 2 17-21 2002 5 93-100 2003 7 5 708-716 Aiello, E. J., Yasui, Y., Tworoger,S. S., Ulrich, C. M., Irwin, M. L., & Bowen, D. et al. (2004). Effects of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopause women. Menopause, 11, 382-388. 44
Alving, B., Ford, L., Friedamn, L., Geller, N., Ludlam, S., McGowan, J. et al. (2004). Effect of conjugated Equine Estrogen in postmenopause women with hysterectomy: The Women s Health Initiative randomized controlled trial. Journal of American Medicine Association, 291, 1701-1712. Daley, A., MacArthur, R., McManus, H., Stokes-Lampard, S., Wilson, A. R., & Mutrie, N. (2006). Factors associated with the use of complementary medicine and non-pharmacological interventions in symptomatic menopausal women. Climacteric, 9, 336-346. Daley, A., MacArthur, C., McManus, R., Stokes-Lampard, H., Wilson, S., Mutrie, N.(2007). Exercise participation,body mass index, and health-related quality of life in women of menopause age.the British Journal of General Practice:the Journal of the Royal College of General Practitioners, 57,130-135. Daley, A., Stokes-Lamppard, H., Mutrie, N., MacArthur, C.(2008).Exercise for vasomotor menopausal symptom(review).cochrance Database of systematic Reviews, 4, Article CD006108. Retrieved March 30, 2009, from http://www.thecochrancelibrary.com. Lindh-Astrand, L., Nedstrand, E., Wyon, Y., & Hammar, M. (2004). Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomized to physical activity or estrogen therapy. Maturitas, 48, 97-105 Robyn, M. A. (2000). Exercise through menopause. ACSM S Health and Fitness Journal, 6 (4), 7-13. Rossouw, J.E., Anderson, G.L., Prentice, R.L., Lacroix, A.Z., Kooperberg, C., Stefanick, M.L. et al. (2002). Risk and benefit of estrogen plus progestin in healthy postmenopausal women:principal results from the Women s Health Initiative randomized controlled trial.journal of American Medicine Association, 288, 321-333. Stadberg, E., Mattisson, L. A., & Milsom, I. (2000). Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstetrica et Gynecologica Scandinavica, 79, 286-192. Whiteman, K. M., Staropoli, C. A., Langenberg, P. W., McCarter. R. J., Hjerulff, 45
K. H., & Flaws, J. A. (2003). Smoking,body mass and hot flushs in midlife women. Obstetrics & Gynecology, 101, 264-272. 46
The Study of Physical Activity and Manifestation of Climacteric Symptoms for Perimenopausal Women of Outpatients of Gynecology & Obstetrics Department Chang Wei-Chie Lin Chun-Feng National Ping-Tung University of Education ABSTRACT The purpose of this study was to understand the current situation of physical activity and manifestation of climacteric symptoms for perimenopausal women of outpatients of gynecology and obstetrics department. In additional, this study also analyzed the relationship between the variables due to the different background factors. By surveying with questionnaire containing short-administration short version of international physical activity questionnaire provided by the bureau of health promotion and adaptation of the Greene s climacteric scale, the questionnaire entitled Physical activity and manifestation of climacteric symptom was distributed to the 134 perimenopausal women who were selected from the gynecology and obstetrics department of Pingtung Armed-force Hospital and Kaohsiung Veteran General Hospital. There were 120 effective questionnaires received and analyzed. We collected the required data and obtained the valid samples. With statistical method and analysis of descriptive statistics, t- test, one-way ANOVA, the major findings are summarized as follows:there was no significant association between levels of physical activity and climacteric symptom. But higher BMI and women with gynecological cancer who had received chemotherapy related to women s experience of symptoms during the natural menopause transition. Key words: physical activity, climateric symptoms 47
48